BMS411

antiviral; potential inhibitor of NS5A protein of hepatitis C virus; structure in first source

Also Known As:

4(((5,5-dimethyl-8-phenyl-5,6-dihydronaphthalen-2-yl)carbonyl)amino)benzoic acid

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Infections 01/01/2017 - "Retinoid BMS411 (4-{[(5,5-dimethyl-8-phenyl-5,6-dihydronaphthalen-2-yl) carbonyl] amino} benzoic acid), a potential inhibitor of NS5A protein of hepatitis C virus, a candidate for combined therapy of hepatitis C infection."
2.	Hepatitis C 01/01/2017 - "Retinoid BMS411 (4-{[(5,5-dimethyl-8-phenyl-5,6-dihydronaphthalen-2-yl) carbonyl] amino} benzoic acid), a potential inhibitor of NS5A protein of hepatitis C virus, a candidate for combined therapy of hepatitis C infection."

1.	Benzoic Acid (Potassium Benzoate)
2.	Retinoids
3.	Proteins (Proteins, Gene)

1.	Therapeutics